Long-Term Follow-Up From MajesTEC-1 of Teclistamab, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)

被引：0

作者：

van de Donk, Niels ^{[1
]}

Moreau, Philippe ^{[2
]}

Garfall, Alfred ^{[3
]}

Bhutani, Manisha ^{[4
]}

Oriol, Albert ^{[5
,6
]}

Nooka, Ajay ^{[7
]}

Martin, Thomas ^{[8
]}

Rosinol, Laura ^{[9
]}

Mateos, Maria-Victoria ^{[10
]}

Bahlis, Nizar ^{[11
]}

Popat, Rakesh ^{[12
]}

Besemer, Britta ^{[13
]}

Martinez Lopez, Joaquin ^{[14
]}

Krishnan, Amrita ^{[15
]}

Delforge, Michel ^{[16
]}

Trancucci, Danielle ^{[17
]}

Verona, Raluca ^{[18
]}

Stephenson, Tara ^{[18
]}

Chastain, Katherine ^{[17
]}

Sidana, Surbhi ^{[19
]}

机构：

[1] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam, Netherlands

[2] Univ Hosp Hotel Dieu, Hematol Clin, Nantes, France

[3] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA USA

[4] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA

[5] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Barcelona, Spain

[6] Hosp Badalona Germans Trias & Pujol, Inst Josep Carreras, Barcelona, Spain

[7] Emory Univ, Winship Canc Inst, Atlanta, GA USA

[8] Univ Calif San Francisco, San Francisco, CA USA

[9] Hosp Clin Barcelona, IDIBAPS, Barcelona, Spain

[10] Univ Hosp Salamanca IBSAL CIC CIBERONC, Salamanca, Spain

[11] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada

[12] NHS Fdn Trust, Univ Coll London Hosp, London, England

[13] Univ Tubingen, Tubingen, Germany

[14] Hematol Hosp 12 Octubre, Madrid, Spain

[15] City Hope Comprehens Canc Ctr, Duarte, CA USA

[16] Univ Leuven, Leuven, Belgium

[17] Janssen Res & Dev, Raritan, NJ USA

[18] Janssen Res & Dev, Spring House, PA USA

[19] Stanford Univ, Sch Med, Stanford, CA USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

relapsed/refractory multiple myeloma; bispecifics; multiple myeloma; phase II;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MM-163

引用

页码：S477 / S478

页数：2